Literature DB >> 12415270

A mouse model of human L1 retrotransposition.

Eric M Ostertag1, Ralph J DeBerardinis, John L Goodier, Yue Zhang, Nuo Yang, George L Gerton, Haig H Kazazian.   

Abstract

The L1 retrotransposon has had an immense impact on the size and structure of the human genome through a variety of mechanisms, including insertional mutagenesis. To study retrotransposition in a living organism, we created a mouse model of human L1 retrotransposition. Here we show that L1 elements can retrotranspose in male germ cells, and that expression of a human L1 element under the control of its endogenous promoter is restricted to testis and ovary. In the mouse line with the highest level of L1 expression, we found two de novo L1 insertions in 135 offspring. Both insertions were structurally indistinguishable from natural endogenous insertions. This suggests that an individual L1 element can have substantial mutagenic potential. In addition to providing a valuable in vivo model of retrotransposition in mammals, these mice are an important step in the development of a new random mutagenesis system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415270     DOI: 10.1038/ng1022

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  93 in total

1.  Hot L1s account for the bulk of retrotransposition in the human population.

Authors:  Brook Brouha; Joshua Schustak; Richard M Badge; Sheila Lutz-Prigge; Alexander H Farley; John V Moran; Haig H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

2.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

Review 3.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

4.  Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.

Authors:  Silke Wissing; Martin Muñoz-Lopez; Angela Macia; Zhiyuan Yang; Mauricio Montano; William Collins; Jose Luis Garcia-Perez; John V Moran; Warner C Greene
Journal:  Hum Mol Genet       Date:  2011-10-11       Impact factor: 6.150

5.  Epigenetic control of retrotransposon expression in human embryonic stem cells.

Authors:  Angela Macia; Martin Muñoz-Lopez; Jose Luis Cortes; Robert K Hastings; Santiago Morell; Gema Lucena-Aguilar; Juan Antonio Marchal; Richard M Badge; Jose Luis Garcia-Perez
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

6.  Intact piRNA pathway prevents L1 mobilization in male meiosis.

Authors:  Simon J Newkirk; Suman Lee; Fiorella C Grandi; Valeriya Gaysinskaya; James M Rosser; Nicole Vanden Berg; Cathryn A Hogarth; Maria C N Marchetto; Alysson R Muotri; Michael D Griswold; Ping Ye; Alex Bortvin; Fred H Gage; Jef D Boeke; Wenfeng An
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

7.  L1 integration in a transgenic mouse model.

Authors:  Daria V Babushok; Eric M Ostertag; Christine E Courtney; Janice M Choi; Haig H Kazazian
Journal:  Genome Res       Date:  2005-12-19       Impact factor: 9.043

Review 8.  Normal and pathological functions of mammalian retroelements.

Authors:  Albert Deisseroth
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

9.  Cell divisions are required for L1 retrotransposition.

Authors:  Xi Shi; Andrei Seluanov; Vera Gorbunova
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

10.  A natural allele of Nxf1 suppresses retrovirus insertional mutations.

Authors:  Jennifer A Floyd; David A Gold; Dorothy Concepcion; Tiffany H Poon; Xiaobo Wang; Elizabeth Keithley; Dan Chen; Erica J Ward; Steven B Chinn; Rick A Friedman; Hon-Tsen Yu; Kazuo Moriwaki; Toshihiko Shiroishi; Bruce A Hamilton
Journal:  Nat Genet       Date:  2003-09-28       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.